Quest Diagnostics rises after quarterly profit beat

Shares of lab operator Quest Diagnostics DGX.N rise 6.7% to $172.67 premarket

DGX posts Q1 adj. profit of $2.21 per share helped by robust demand for its diagnostic tests, beating analysts' estimates of $2.15, according to data compiled by LSEG

Company reports Q1 revenue of $2.65 billion vs estimates of $2.63 billion

Company continues to expect annual adj. profit in the range of $9.55 and $9.80 per share vs estimates of $9.68

DGX maintains its annual net revenue forecast in the range of $10.70 billion to $10.85 billion vs estimates of $10.78 billion

As of last close, DGX had risen 7.3% YTD